ArticlePloS one2022
Robust and efficient COVID-19 detection techniques: A machine learning approach.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- Review on the Evaluation and Development of Artificial Intelligence for COVID-19 Containment.Sensors (Basel, Switzerland) · 2023Review
- Article
- Predicting health insurance uptake in Kenya using Random Forest: An analysis of socio-economic and demographic factors.PloS one · 2023Article
- An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study.Metabolites · 2022Article
- Recommender System for the Efficient Treatment of COVID-19 Using a Convolutional Neural Network Model and Image Similarity.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The devastating impact of the Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) pandemic almost halted the global economy and is responsible for 6 million deaths with infection rates of over 524 million. With significant reservations, initially, the SARS-CoV-2 virus was suspected to be infected by and closely related to Bats. However, over the periods of learning and critical development of experimental evidence, it is found to have some similarities with several gene clusters and virus proteins identified in animal-human transmission. Despite this substantial evidence and learnings, there is limited exploration regarding the SARS-CoV-2 genome to putative microRNAs (miRNAs) in the virus life cycle. In this context, this paper presents a detection method of SARS-CoV-2 precursor-miRNAs (pre-miRNAs) that helps to identify a quick detection of specific ribonucleic acid (RNAs). The approach employs an artificial neural network and proposes a model that estimated accuracy of 98.24%. The sampling technique includes a random selection of highly unbalanced datasets for reducing class imbalance following the application of matriculation artificial neural network that includes accuracy curve, loss curve, and confusion matrix. The classical approach to machine learning is then compared with the model and its performance. The proposed approach would be beneficial in identifying the target regions of RNA and better recognising of SARS-CoV-2 genome sequence to design oligonucleotide-based drugs against the genetic structure of the virus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.